These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25220032)

  • 21. Immunosuppressive properties of Wharton's jelly-derived mesenchymal stromal cells in vitro.
    He H; Nagamura-Inoue T; Takahashi A; Mori Y; Yamamoto Y; Shimazu T; Tsunoda H; Tojo A
    Int J Hematol; 2015 Sep; 102(3):368-78. PubMed ID: 26228529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation and characterisation of human umbilical cord derived mesenchymal stem cells by explant method.
    Yusoff Z; Maqbool M; George E; Hassan R; Ramasamy R
    Med J Malaysia; 2016 Jun; 71(3):105-10. PubMed ID: 27495882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive function of mesenchymal stem cells from human umbilical cord matrix in immune thrombocytopenia patients.
    Ma L; Zhou Z; Zhang D; Yang S; Wang J; Xue F; Yang Y; Yang R
    Thromb Haemost; 2012 May; 107(5):937-50. PubMed ID: 22398715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Umbilical Cord Mesenchymal Stem Cells Inhibit the Function of Allogeneic Activated Vγ9Vδ2 T Lymphocytes In Vitro.
    Liu X; Feng T; Gong T; Shen C; Zhu T; Wu Q; Li Q; Li H
    Biomed Res Int; 2015; 2015():317801. PubMed ID: 25984529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Umbilical cord-derived mesenchymal stem cells isolated by a novel explantation technique can differentiate into functional endothelial cells and promote revascularization.
    Xu Y; Meng H; Li C; Hao M; Wang Y; Yu Z; Li Q; Han J; Zhai Q; Qiu L
    Stem Cells Dev; 2010 Oct; 19(10):1511-22. PubMed ID: 20170363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Banking human umbilical cord-derived mesenchymal stromal cells for clinical use.
    Gong W; Han Z; Zhao H; Wang Y; Wang J; Zhong J; Wang B; Wang S; Wang Y; Sun L; Han Z
    Cell Transplant; 2012; 21(1):207-16. PubMed ID: 21929848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation, characterisation and comparative analysis of human umbilical cord vein perivascular cells and cord blood mesenchymal stem cells.
    Gökçinar-Yagci B; Özyüncü Ö; Çelebi-Saltik B
    Cell Tissue Bank; 2016 Jun; 17(2):345-52. PubMed ID: 26679930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive properties of mesenchymal stromal cell cultures derived from the limbus of human and rabbit corneas.
    Bray LJ; Heazlewood CF; Munster DJ; Hutmacher DW; Atkinson K; Harkin DG
    Cytotherapy; 2014 Jan; 16(1):64-73. PubMed ID: 24094499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative xeno-free biomaterials derived from human umbilical cord for the self-renewal ex-vivo expansion of mesenchymal stem cells.
    Kim SM; Moon SH; Lee Y; Kim GJ; Chung HM; Choi YS
    Stem Cells Dev; 2013 Nov; 22(22):3025-38. PubMed ID: 23786292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dramatic differences in activity of purines metabolizing ecto-enzymes between mesenchymal stem cells isolated from human umbilical cord blood and umbilical cord tissue.
    Roszek K; Bomastek K; Drożdżal M; Komoszyński M
    Biochem Cell Biol; 2013 Dec; 91(6):519-25. PubMed ID: 24219295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of HLA-G and Related Immunosuppressive Effects in Human Umbilical Cord Stroma-Derived Stem Cells.
    Ding DC; Chou HL; Chang YH; Hung WT; Liu HW; Chu TY
    Cell Transplant; 2016; 25(2):217-28. PubMed ID: 26044082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoinduction in umbilical cord- and palate periosteum-derived mesenchymal stem cells.
    Caballero M; Reed CR; Madan G; van Aalst JA
    Ann Plast Surg; 2010 May; 64(5):605-9. PubMed ID: 20395805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
    Chen MY; Lie PC; Li ZL; Wei X
    Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton's jelly matrix.
    Hendijani F; Sadeghi-Aliabadi H; Haghjooy Javanmard S
    Cell Tissue Bank; 2014 Dec; 15(4):555-65. PubMed ID: 24532125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of mesenchymal stem cells using the total length of umbilical cord for transplantation purposes.
    Tsagias N; Koliakos I; Karagiannis V; Eleftheriadou M; Koliakos GG
    Transfus Med; 2011 Aug; 21(4):253-61. PubMed ID: 21623971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation.
    Friedman R; Betancur M; Boissel L; Tuncer H; Cetrulo C; Klingemann H
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1477-86. PubMed ID: 18022578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a new standardized enzymatic isolation protocol for human umbilical cord-derived stem cells.
    Buyl K; Vanhaecke T; Desmae T; Lagneaux L; Rogiers V; Najar M; De Kock J
    Toxicol In Vitro; 2015 Sep; 29(6):1254-62. PubMed ID: 25541070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the paracrine activity of mesenchymal stem cells derived from human umbilical cord, amniotic membrane and adipose tissue.
    Dabrowski FA; Burdzinska A; Kulesza A; Sladowska A; Zolocinska A; Gala K; Paczek L; Wielgos M
    J Obstet Gynaecol Res; 2017 Nov; 43(11):1758-1768. PubMed ID: 28707770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases.
    Mebarki M; Iglicki N; Marigny C; Abadie C; Nicolet C; Churlaud G; Maheux C; Boucher H; Monsel A; Menasché P; Larghero J; Faivre L; Cras A
    Stem Cell Res Ther; 2021 Nov; 12(1):571. PubMed ID: 34774107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High yield recovery of equine mesenchymal stem cells from umbilical cord matrix/Wharton's jelly using a semi-automated process.
    Nazari-Shafti TZ; Bruno IG; Martinez RF; Coleman ME; Alt EU; McClure SR
    Methods Mol Biol; 2015; 1235():131-46. PubMed ID: 25388392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.